Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jun 15, 2022; 14(6): 1162-1174
Published online Jun 15, 2022. doi: 10.4251/wjgo.v14.i6.1162
Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer
Cristina Díaz del Arco, Lourdes Estrada Muñoz, Luis Ortega Medina, Elena Molina Roldán, M Ángeles Cerón Nieto, Soledad García Gómez de las Heras, M Jesús Fernández Aceñero
Cristina Díaz del Arco, Luis Ortega Medina, Elena Molina Roldán, M Ángeles Cerón Nieto, M Jesús Fernández Aceñero, Department of Surgical Pathology, Hospital Clínico San Carlos, Madrid 28040, Spain
Cristina Díaz del Arco, Luis Ortega Medina, M Jesús Fernández Aceñero, Department of Legal Medicine, Psychiatry and Pathology, Complutense University of Madrid, Madrid 28040, Spain
Lourdes Estrada Muñoz, Department of Surgical Pathology, Hospital Rey Juan Carlos, Madrid 28933, Spain
Lourdes Estrada Muñoz, Soledad García Gómez de las Heras, Department of Basic Medical Sciences, Rey Juan Carlos University, Madrid 28933, Spain
Author contributions: Díaz del Arco C participated in the data acquisition, analysis, interpretation, manuscript draft, approval and agreement; Estrada Muñoz L participated in the data acquisition, analysis, manuscript revision, approval and agreement; Ortega Medina L participated in the study design, data interpretation, manuscript revision, approval and agreement; Molina Roldán E, Cerón Nieto MA, García Gómez de las Heras S participated in the data acquisition, manuscript revision, approval and agreement; Fernández Aceñero MJ participated in the study design, data analysis and interpretation, manuscript draft, approval and agreement.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Hospital Clínico San Carlos.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: Data will be available on request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Cristina Díaz del Arco, MD, Staff Physician, Associate Professor, Department of Surgical Pathology, Hospital Clínico San Carlos, c/ Profesor Martín Lagos s/n, Madrid 28040, Spain. crisdelarco@gmail.com
Received: December 30, 2021
Peer-review started: December 30, 2021
First decision: March 13, 2022
Revised: April 1, 2022
Accepted: May 27, 2022
Article in press: May 27, 2022
Published online: June 15, 2022
Processing time: 161 Days and 15.1 Hours
Core Tip

Core Tip: In the molecular era, the Laurén system is a cost-effective and widely implemented classification. The identification of easily available prognostic factors in intestinal and diffuse-type tumors may significantly improve patient stratification in gastric cancer (GC). In this study, the authors found that intestinal and diffuse-type GC show different epidemiological, clinical and prognostic features. Laurén subtypes were also associated with different risk factors for tumor progression and death. Finally, separate clinicopathological scores for patients with intestinal and diffuse-type GC showed an excellent prognostic stratification. The development of specific prognostic scores is a useful, cost-effective strategy to improve risk assessment in GC.